Sep 30, 2025 • Benzinga
NEUTRAL
MoonLake Immunotherapeutics ( MLTX ) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman - MoonLake ( NASDAQ:MLTX )
SAN FRANCISCO, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- Investors in MoonLake Immunotherapeutics ( NASDAQ:MLTX ) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly anticipated treatment for patients with ...
Sep 30, 2025 • Benzinga
NEUTRAL
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - MoonLake ( NASDAQ:MLTX )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options
Sep 29, 2025 • Benzinga
SOMEWHAT-BULLISH
MLTX BREAKING NEWS: BFA Law is Investigating MoonLake Immunotherapeutics ( NASDAQ: MLTX ) for Securities Fraud after Stock Drops 90% on Drug Trial Results, Investors Urged to Contact the Firm - MoonLake ( NASDAQ:MLTX )
NEW YORK, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics ( NASDAQ: MLTX ) for potential violations of the federal securities laws.
Sep 29, 2025 • Benzinga
SOMEWHAT-BULLISH
MoonLake Immunotherapeutics Stock Plummets - MoonLake ( NASDAQ:MLTX )
MoonLake Immunotherapeutics' ( NASDAQ: MLTX ) stock price fell off a cliff Monday after it reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials. The trials used HiSCR75-a 75% reduction in abscess and inflammatory nodule count with no increase in abscesses or draining tunnels-as ...
Sep 29, 2025 • Benzinga
SOMEWHAT-BULLISH
Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings - Carnival ( NYSE:CCL ) , Better Home & Finance ( NASDAQ:BETR )
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded down 0.12% to 46,190.92 while the NASDAQ rose 0.40% to 22,574.89. The S&P 500 also rose, gaining, 0.13% to 6,652.27. Information technology shares jumped by 0.6% on Monday.
Sep 29, 2025 • Benzinga
NEUTRAL
BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses - MoonLake ( NASDAQ:MLTX )
BOSTON, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating MoonLake Immunotherapeutics ( NASDAQ: MLTX ) for potential securities law violations. Investors who have lost money in their MoonLake Immunotherapeutics investment should contact the firm to learn more about how they ...